US research roundup: Cabot, Ionis Pharmaceuticals, Tesla
IONS•Analysts cut price targets for Cabot to $68 from $78, Ionis Pharmaceuticals to $54 from $86, and Tesla to $375 from $400. The roundup also includes target changes and rating actions on dozens of other US-listed companies.
1. Selected target cuts
JP Morgan cut its target price for Cabot to $68 from $78. Needham cut its target for Ionis Pharmaceuticals to $54 from $86, while Jefferies cut its Tesla target to $375 from $400.
2. Other analyst actions
The roundup lists research actions on dozens of companies, including multiple target-price cuts for Ionis and rating and target changes across sectors.
